🔎 Trials Near Me

Home › Stomach Cancer › Texas › Dallas

Stomach Cancer clinical trials in Dallas, TX

19 studies for Stomach Cancer are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

RecruitingPhase 1
  • UT Southwestern, Dallas
Ages 19 and older · All sexes · Updated Oct 1, 2026 · NCT06586957

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

RecruitingPhase 1/2
  • Baylor, Scott and White Research Institute, Dallas
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06047379

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

RecruitingPhase 1
  • Texas Oncology - DFW (Sammons CC), Dallas
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

RecruitingPhase 1
  • Texas Oncology - DFW (Sammons CC), Dallas
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07213791

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

RecruitingPhase 1/2
  • Mary Crowley Cancer Research, Dallas
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06750185

A Phase 1/1b Study of IAM1363 in HER2 Cancers

RecruitingPhase 1
  • Mary Crowley Cancer Research, Dallas
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06253871

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

RecruitingPhase 3
  • UT Southwestern Medical Center, Dallas
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06731478

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

RecruitingPhase 1/2
  • Texas Oncology, Dallas
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT03526835

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

RecruitingPhase 1
  • University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
  • UT Southwestern Medical Center - Redbird, Dallas
  • Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
  • and 2 more
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT05208762

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

RecruitingPhase 2
  • Texas Oncology - DFW, Dallas
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT06695845

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

RecruitingPhase 2
  • Texas Oncology Dallas Methodist, Dallas
  • Texas Oncology Dallas Medical City, Dallas
  • Texas Oncology Dallas Presbyterian, Dallas
  • and 2 more
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT06038578

[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

RecruitingPhase 1/2
  • University of Texas Southwestern Medical Center, Dallas
Ages 18 to 80 · All sexes · Updated Jun 23, 2026 · NCT07432633

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

RecruitingPhase 1
  • Baylor University Medical Center, Dallas
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT05768932

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

RecruitingPhase 1
  • NEXT Dallas, Dallas
Ages 18 and older · All sexes · Updated Jan 21, 2026 · NCT07317505

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

RecruitingPhase 1
  • Dren Investigational Site, Dallas
Ages 18 and older · All sexes · Updated Jan 7, 2026 · NCT06999187

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Dallas
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

RecruitingPhase 1/2
  • Mary Crowley Cancer Research, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Ages 18 and older · All sexes · Updated Sep 24, 2025 · NCT05941507

About Stomach Cancer

Did you know risk factors for stomach (gastric) cancer include a diet high in salty or smoked food or having an H. pylori infection? Learn more here.

More about Stomach Cancer on MedlinePlus

Stomach Cancer trials in other cities

Other studies in Dallas

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.